Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis

Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder

(2012) Marc De Hert et al.   CNS DRUGS

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

(2011) Marc De Hert et al.   Nature Reviews Endocrinology

Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis

(2010) Nicolas A. Crossley et al.   BRITISH JOURNAL OF PSYCHIATRY

Past and Present Progress in the Pharmacologic Treatment of Schizophrenia

(2010) John M. Kane et al.   JOURNAL OF CLINICAL PSYCHIATRY

Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients

(2010) Jimmi Nielsen et al.   NEUROPSYCHOPHARMACOLOGY

Antipsychotic Dose Equivalents and Dose-Years: A Standardized Method for Comparing Exposure to Different Drugs

(2009) Nancy C. Andreasen et al.   BIOLOGICAL PSYCHIATRY

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Schizophrenia

(2009) Jim van Os et al.   LANCET

Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study

(2008) Linmarie Sikich et al.   AMERICAN JOURNAL OF PSYCHIATRY

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

(2008) René S Kahn et al.   LANCET

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

(2008) Stefan Leucht et al.   LANCET

Typical and Atypical Antipsychotics – The Misleading Dichotomy

(2008) David Fischer-Barnicol et al.   NEUROPSYCHOBIOLOGY

Metabolic syndrome in first episode schizophrenia — A randomized double-blind controlled, short-term prospective study

(2008) Sahoo Saddichha et al.   SCHIZOPHRENIA RESEARCH